News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
48,177 Results
Type
Article (3774)
Company Profile (9)
Press Release (44391)
Multimedia
Podcasts (15)
Webinars (5)
Section
Business (12464)
Career Advice (166)
Deals (2170)
Drug Delivery (10)
Drug Development (6373)
Employer Resources (8)
FDA (1617)
Job Trends (1283)
News (22735)
Policy (2403)
Tag
Academia (282)
Accelerated approval (3)
Adcomms (6)
Allergies (17)
Alliances (3266)
ALS (18)
Alzheimer's disease (167)
Antibody-drug conjugate (ADC) (20)
Approvals (1622)
Artificial intelligence (45)
Autoimmune disease (14)
Automation (5)
Bankruptcy (11)
Best Places to Work (1082)
BIOSECURE Act (1)
Biosimilars (15)
Biotechnology (4)
Bladder cancer (13)
Brain cancer (10)
Breast cancer (56)
Cancer (330)
Cardiovascular disease (38)
Career advice (154)
Career pathing (8)
CAR-T (16)
CDC (5)
Cell therapy (66)
Cervical cancer (1)
Clinical research (5431)
Collaboration (128)
Compensation (36)
Complete response letters (5)
COVID-19 (289)
CRISPR (7)
C-suite (91)
Cystic fibrosis (3)
Data (521)
Denatured (3)
Depression (26)
Diabetes (27)
Diagnostics (462)
Digital health (4)
Diversity (3)
Diversity, equity & inclusion (3)
Drug discovery (23)
Drug pricing (20)
Drug shortages (1)
Duchenne muscular dystrophy (35)
Earnings (3776)
Editorial (16)
Employer branding (1)
Employer resources (8)
Events (6198)
Executive appointments (79)
FDA (1855)
Friedreich's ataxia (5)
Frontotemporal dementia (5)
Funding (112)
Gene editing (19)
Generative AI (7)
Gene therapy (94)
GLP-1 (85)
Government (509)
Guidances (35)
Healthcare (1492)
HIV (14)
Huntington's disease (5)
IgA nephropathy (4)
Immunology and inflammation (17)
Immuno-oncology (4)
Indications (10)
Infectious disease (323)
Inflammatory bowel disease (10)
Inflation Reduction Act (4)
Influenza (17)
Intellectual property (6)
Interviews (29)
IPO (934)
IRA (4)
Job creations (237)
Job search strategy (112)
JPM (12)
Kidney cancer (1)
Labor market (11)
Layoffs (32)
Leadership (9)
Legal (446)
Liver cancer (7)
Longevity (4)
Lung cancer (52)
Lymphoma (18)
Machine learning (7)
Management (2)
Manufacturing (79)
MASH (10)
Medical device (935)
Medtech (937)
Mergers & acquisitions (1312)
Metabolic disorders (76)
Multiple sclerosis (27)
NASH (4)
Neurodegenerative disease (48)
Neuropsychiatric disorders (13)
Neuroscience (329)
NextGen: Class of 2026 (648)
Non-profit (574)
Now hiring (4)
Obesity (40)
Opinion (49)
Ovarian cancer (10)
Pain (16)
Pancreatic cancer (3)
Parkinson's disease (34)
Partnered (6)
Patents (19)
Patient recruitment (31)
Peanut (8)
People (4461)
Pharmaceutical (1)
Pharmacy benefit managers (4)
Phase 1 (1604)
Phase 2 (2267)
Phase 3 (2042)
Pipeline (383)
Policy (39)
Postmarket research (184)
Preclinical (593)
Press Release (3)
Prostate cancer (21)
Psychedelics (4)
Radiopharmaceuticals (15)
Rare diseases (95)
Real estate (563)
Recruiting (3)
Regulatory (1936)
Reports (7)
Research institute (218)
Resumes & cover letters (24)
Rett syndrome (1)
RNA editing (1)
RSV (6)
Schizophrenia (11)
Series A (22)
Series B (16)
Service/supplier (1)
Sickle cell disease (8)
Special edition (5)
Spinal muscular atrophy (13)
Sponsored (8)
Startups (331)
Stomach cancer (1)
Supply chain (8)
Tariffs (11)
The Weekly (11)
Vaccines (114)
Venture capital (15)
Weight loss (28)
Women's health (9)
Worklife (2)
Date
Last 7 days (35)
Last 30 days (154)
Last 365 days (2077)
2026 (193)
2025 (2137)
2024 (2430)
2023 (2803)
2022 (4056)
2021 (4169)
2020 (4200)
2019 (4407)
2018 (3369)
2017 (2267)
2016 (2225)
2015 (2677)
2014 (1843)
2013 (1426)
2012 (1513)
2011 (1563)
2010 (1140)
Location
Africa (63)
Alabama (3)
Arizona (8)
Asia (2995)
Australia (400)
California (625)
Canada (176)
China (112)
Colorado (20)
Connecticut (29)
Delaware (25)
Europe (6553)
Florida (88)
Georgia (18)
Hawaii (1)
Idaho (4)
Illinois (62)
India (4)
Indiana (27)
Japan (34)
Kansas (13)
Kentucky (4)
Louisiana (5)
Maine (1)
Maryland (91)
Massachusetts (546)
Michigan (15)
Minnesota (42)
Missouri (6)
Montana (2)
Nebraska (1)
Nevada (10)
New Hampshire (6)
New Jersey (265)
New Mexico (5)
New York (151)
North Carolina (89)
Northern California (333)
Ohio (23)
Oklahoma (2)
Oregon (5)
Pennsylvania (164)
Puerto Rico (2)
Rhode Island (4)
South America (121)
South Carolina (8)
Southern California (193)
Tennessee (6)
Texas (148)
United States (2535)
Utah (26)
Vermont (1)
Virginia (16)
Washington D.C. (4)
Washington State (58)
Wisconsin (10)
48,177 Results for "green cross labcell".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Overcoming the Wall: How Far Has BBB-Crossing Antibody Technology Truly Advanced? - Commentary by Unexakorea
January 26, 2026
·
4 min read
Press Releases
Bio Green Med Solution Reports Third Quarter Financial Results and Provides Business Update
November 14, 2025
·
8 min read
Press Releases
Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering
December 8, 2025
·
3 min read
Press Releases
ToolGen and GenEditBio Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics
November 24, 2025
·
5 min read
Press Releases
Agilent Refurbishment Centers Achieve Top-Level My Green Lab Certification
September 10, 2025
·
3 min read
Deals
JPM26: Attendees Wonder, Where’s Our Big M&A Deal?
There hasn’t been a headline-stealing deal at J.P. Morgan yet. Nevertheless, the mood is positive amid green shoots and a flurry of dealmaking to end 2025.
January 13, 2026
·
2 min read
·
Annalee Armstrong
FDA
FDA Demurs on GLP-1 Compounding Fight, Debuts Consumer ‘Green List’ Instead
While a win for consumers, the regulatory action did nothing to stem the manufacture of compounded versions of the popular obesity drugs that are made by Novo Nordisk and Eli Lilly. In fact, the FDA seems to be signaling that “some level of compounded product is acceptable,” according to BMO Capital Markets.
September 8, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Chiesi Group Enters into an Exclusive License Agreement with Aliada Therapeutics, a Wholly Owned Subsidiary of AbbVie, to Advance Blood-Brain Barrier-Crossing Platform Technology in Lysosomal Storage Disorders
November 13, 2025
·
3 min read
Press Releases
NeoGenomics Appoints Dr. Marjorie Green to Board of Directors
June 24, 2025
·
4 min read
Press Releases
Ulteeva Purity™ Fiber Expands in Blue and Debuts in Green — Now Available for Sampling
July 7, 2025
·
1 min read
1 of 4,818
Next
